Life Sciences | McCarter & English, LLP

Our Life Sciences team brings substantial experience in the pharmaceutical, medical device, biotechnology, and healthcare fields to established organizations and startup life sciences ventures.

Our knowledge base in these industries has earned our firm a seat at the table when these companies make far-reaching decisions ranging from structuring clinical trials and raising venture capital to pursuing in-depth research into groundbreaking medicines and devices. We bring extensive hands-on experience in protecting the valuable intellectual property that feeds the long-term success of these enterprises. This close link between company and legal teams allows our Life Sciences practitioners to solve new and compelling issues and to pave the way for risk avoidance and financial success.

Our range of experience on behalf of life sciences companies and healthcare groups includes representing them in sophisticated financing transactions, such as public offerings, venture capital investments, and private placement of securities. We also protect brands that represent billions of dollars in development and marketing and assess product risk during the clinical trial phase of the drug approval process. Our team is well versed in managing environmental, real estate, employment, and tax issues as well as serving as lead, national, or principal counsel in class-action pharmaceutical and medical device mass liability cases involving some of the most well-known drugs and devices in the world.

We serve life sciences companies in nearly every aspect of their businesses and operations, ensuring future growth and increasing market share by:

Assessing legal risks during the product development stage
Assisting in obtaining governmental clearances
Facilitating funding efforts through venture capital sources
Navigating through increasingly complex privacy laws and regulations, particularly in the health care field
Guarding intellectual property through strategic counseling and, if necessary, in patent infringement, trademark infringement and false advertising litigation
Building on our high technology and information systems experience as these disciplines converge at the frontier of research and development
Prosecuting and defending commercial, product liability, and tort litigation matters with decades of litigation and trial experience nationwide

Defending a multinational branded pharmaceutical company in MDL and coordinated state court litigation in the Delaware Superior Court concerning proton pump inhibitors.

Serving on the defense steering committee and as national discovery counsel to a major multinational pharmaceutical business in ongoing and high-profile litigation alleging a class of heartburn drugs cause chronic kidney disease, renal failure, or other kidney problems. The representation involves over 10,000 cases, and includes appearing in Court and advising on all discovery issues related to In Re: Proton-Pump Inhibitor Products Liability Litigation, a multi-district litigation in the U.S. District Court, District of New Jersey, and in numerous state courts across the country.

Counsel for global pharmaceutical manufacturer in defense of thousands of lawsuits alleging ingestion injuries.

Secured an order granting our motion to exclude plaintiffs’ expert testimony, and then successfully moved for summary judgment, resulting in the dismissal of all remaining plaintiffs in an MDL involving claims that a pharmaceutical innovator’s acid reflux treatment drug caused bone fractures.

Serving as national discovery counsel and a member of the national trial and leadership teams representing a major innovator pharmaceutical company in the defense of over 25,000 claims that an antipsychotic medication causes weight gain, diabetes, and pancreatitis.

Represented a major innovator pharmaceutical company in the defense of personal injury cases which involved claims that pain pumps cause degeneration of shoulder joint cartilage.

Serving as national coordinating counsel for a major innovator pharmaceutical company in the defense of hundreds of claims that treatment with a widely prescribed branded statin causes diabetes, cardiovascular problems, and liver and kidney problems.

Serving as trial counsel for a multinational branded pharmaceutical company in both Philadelphia Court of Common Pleas and the U.S. District Court for the District of Delaware concerning atypical antipsychotics.

Defending branded pharmaceutical company in litigation filed in Delaware state court by the Delaware Attorney General seeking damages in connection with the use of opioids.

Browse Alphabetically:

Representative Matters

Highlights

Recognitions